EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients ...

St. Luke’s Medical Center (SLMC) has opened an inhaler clinic service specifically designed to cater to patients with ...

Discover how cell-based therapy is emerging as a promising treatment option for COPD patients. Learn about its benefits, ...

Patients with chronic obstructive pulmonary disease (COPD) that is in a state of disease stability (DS) have fewer exacerbations and lower mortality, according to study findings published in Chest.

India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...

In both adults with and without self-reported COPD, a 6- or 12-week course of cytisinicline helped more daily smokers achieve ...

If you are a COPD patient you may be at risk of flare-ups in the colder months. Check out the expert-approved tips which reduce the triggers.

'The tunnels were wet, flooded in places, and there was bird faeces everywhere' ...

In an analysis adjusted for tobacco cigarette use, the likelihood for asthma and COPD significantly rose with daily cannabis ...

The arrival of cold weather can exacerbate the condition, causing difficulty in breathing due to airway irritation, pollution and viral infections. In winter, a lot of patients have frequent wheeze, ...

ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients Glasmacinal, a novel macrolide, was well tolerated and reduced neutrophilic inflammation in COPD patients ...

A shock survey by charity Asthma + Lung UK reveals that more than 90% of people with COPD are receiving inadequate care ...